Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer

W Jiang, M Ji - Seminars in Cancer Biology, 2019 - Elsevier
Abstract The phosphoinositide 3-kinase (PI3K) pathway, one of the most commonly
activated signaling pathways in human cancers, plays a crucial role in the regulation of cell …

Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications

S Camorani, E Crescenzi, M Fedele… - Biochimica et Biophysica …, 2018 - Elsevier
Transmembrane receptor tyrosine kinases (RTKs) play crucial roles in cancer cell
proliferation, survival, migration and differentiation. Area of intense research is searching for …

[HTML][HTML] Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer

S Camorani, BS Hill, F Collina, S Gargiulo… - Theranostics, 2018 - ncbi.nlm.nih.gov
While the overall mortality for breast cancer has recently declined, management of triple-
negative breast cancer (TNBC) is still challenging because of its aggressive clinical …

Molecular mechanisms of stem/progenitor cell maintenance in the adrenal cortex

AM Lerario, I Finco, C LaPensee… - Frontiers in …, 2017 - frontiersin.org
The adrenal cortex is characterized by three histologically and functionally distinct zones:
the outermost zona glomerulosa (zG), the intermediate zona fasciculata, and the innermost …

Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER

S Moradi-Kalbolandi, A Hosseinzade… - Journal of Pharmacy …, 2018 - academic.oup.com
Objectives Monoclonal antibody-based of cancer therapy has been considered as one of the
most successful therapeutic strategies for both haematologic malignancies and solid …

[引用][C] Mitogen-Activated Protein Kinase (MAPK) Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma

S Dash, S Chava, Y Aydin, JJ Buell, T Wu, AJ Cohen